NIH-funded research R01 grant

How APOE and brain sugars (heparan sulfate) interact in Alzheimer's

Official title: ApoE and Heparan Sulfate Interaction in Alzheimer’s Disease

Funded at Rensselaer Polytechnic Institute · NIH-11309158 · Data updated 2026-11-12

Researchers are looking at whether different versions of the APOE gene change how APOE protein binds to sugars called heparan sulfate in the brain, which may help explain Alzheimer’s risk in older adults.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRensselaer Polytechnic Institute
NIH-funded
Lab location1 site (Troy, United States)
Project startMay 15, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$745,430
NIH project number5R01AG087305-03
Project IDNIH-11309158 on NIH RePORTER

Who could benefit from this research

Could help

This is a laboratory and animal-focused project that does not enroll patients, although its findings are most relevant to people with Alzheimer’s disease and carriers of the APOE-ε4 risk allele.

Less likely to help

People without Alzheimer’s disease or without APOE-related genetic risk are unlikely to see direct benefits from this specific basic-science project in the near term.

What this research studies

From a patient’s perspective, the team will examine human Alzheimer’s brain tissue to see how APOE proteins stick to heparan sulfate sugars on brain cells. They will determine the exact molecular contacts between different APOE forms using high-resolution structural methods. The researchers will then test how those differences affect cells and animals to understand potential effects on disease processes. Together these steps aim to connect genetic risk (APOE types) to specific biological mechanisms in the brain.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or treat APOE-linked Alzheimer’s by blocking harmful APOE–heparan sulfate interactions.

How similar studies have gone: Previous research has shown links between APOE and heparan sulfate in Alzheimer’s brains, but the isoform-specific, atomic-level mechanisms proposed here are relatively novel.

Where this research is happening

  • Rensselaer Polytechnic Institute
    Troy, United States
    Active

Researchers

  • Principal investigator: Wang, Chunyu — Rensselaer Polytechnic Institute
  • Study coordinator: Wang, Chunyu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.